JUL 29, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Mycophenolate Mofetil (REMS)
U.S. Food and Drug Administration
FDA supplemental approval of a Risk Evaluation and Mitigation Strategy (REMS) for mycophenolate mofetil; regulatory action establishing safety management requirements, not clinical efficacy evidence.